Skip to main content
Fig. 4 | Porcine Health Management

Fig. 4

From: Evaluation of the clinical efficacy of a water soluble formulation of tylvalosin in the control of enzootic pneumonia associated with Mycoplasma hyopneumoniae and Pasteurella multocida in pigs

Fig. 4

Incidence of new clinical cases for tylvalosin pigs (TVN group) and untreated pigs (CTL group) in the healthy population (data of 2 sites combined). Pigs in the TVN pens received Aivlosin in drinking water at 10 mg tylavlosin/kg body weight daily for 5 consecutive days. Pigs in the CTL pens were left untreated. A pig was clased as new case if it was deemed healthy at the start of the evaluation period but met the clinically affected criteria (see Table 4) up to Day 13. *Log-rank P-value from testing homogeneity of survival curves for event day over strata indicates more new cases in untreated pigs

Back to article page

Porcine Health Management

ISSN: 2055-5660

Contact us